Nanoviricides Inc (NNVC)
1.42
-0.01
(-0.70%)
USD |
NYAM |
Nov 01, 16:00
1.415
0.00 (0.00%)
After-Hours: 20:00
Nanoviricides Enterprise Value: 16.04M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 16.04M |
| October 31, 2024 | 16.19M |
| October 30, 2024 | 15.16M |
| October 29, 2024 | 16.34M |
| October 28, 2024 | 17.51M |
| October 25, 2024 | 17.14M |
| October 24, 2024 | 17.07M |
| October 23, 2024 | 16.92M |
| October 22, 2024 | 17.22M |
| October 21, 2024 | 16.78M |
| October 18, 2024 | 16.92M |
| October 17, 2024 | 17.07M |
| October 16, 2024 | 17.36M |
| October 15, 2024 | 17.22M |
| October 14, 2024 | 16.19M |
| October 11, 2024 | 17.07M |
| October 10, 2024 | 15.31M |
| October 09, 2024 | 15.46M |
| October 08, 2024 | 16.04M |
| October 07, 2024 | 15.31M |
| October 04, 2024 | 16.78M |
| October 03, 2024 | 15.90M |
| October 02, 2024 | 17.07M |
| October 01, 2024 | 16.63M |
| September 30, 2024 | 17.22M |
| Date | Value |
|---|---|
| September 27, 2024 | 16.48M |
| September 26, 2024 | 13.87M |
| September 25, 2024 | 12.95M |
| September 24, 2024 | 14.26M |
| September 23, 2024 | 15.44M |
| September 20, 2024 | 15.84M |
| September 19, 2024 | 15.97M |
| September 18, 2024 | 17.02M |
| September 17, 2024 | 16.10M |
| September 16, 2024 | 14.92M |
| September 13, 2024 | 16.36M |
| September 12, 2024 | 17.28M |
| September 11, 2024 | 16.63M |
| September 10, 2024 | 16.23M |
| September 09, 2024 | 15.44M |
| September 06, 2024 | 17.42M |
| September 05, 2024 | 18.73M |
| September 04, 2024 | 18.07M |
| September 03, 2024 | 18.60M |
| August 30, 2024 | 20.83M |
| August 29, 2024 | 19.91M |
| August 28, 2024 | 20.31M |
| August 27, 2024 | 21.62M |
| August 26, 2024 | 21.49M |
| August 23, 2024 | 20.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.466M
Minimum
May 12 2022
124.76M
Maximum
Jan 31 2020
19.69M
Average
14.91M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.615M |
| Palatin Technologies Inc | 13.93M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.69M |
| Oragenics Inc | 1.901M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.356M |
| Total Expenses (Quarterly) | 2.391M |
| EPS Diluted (Quarterly) | -0.19 |
| Earnings Yield | -49.30% |